| Literature DB >> 27193717 |
V I Aksenova1, G S Kopeina2, A V Zamaraev1, B D Zhivotovsky1,3, I N Lavrik1,3.
Abstract
The mechanism of caspase-2 activation in response to DNA damage was studied using human ovarian cancer cells Caov-4 treated with chemotherapeutic agent cisplatin. It was shown that mutations of the three cleavage sites of caspase-2 do not affect the assembly of the macromolecular complex of caspase-2 and its activation, but, conversely, stabilize this complex, most likely, via the inhibition of the dissociation of the active caspase-2.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27193717 DOI: 10.1134/S1607672916020150
Source DB: PubMed Journal: Dokl Biochem Biophys ISSN: 1607-6729 Impact factor: 0.788